HA

Hansa Agarwal

Director Director DIN 03347556
DIN 03347556 First appointment Feb 2011 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2011
Shareholding value •••• Premium profile

About Hansa Agarwal

Data last updated:

Hansa Agarwal was a Director at Triveni Medichem Private Limited (2011–2025) and Director at Avk Impex Private Limited (2012–2016). The companies operate in Chemicals and Materials and Home Appliances.

DIN 03347556
Primary Designation Director
Industry Chemicals and Materials
First Appointment 12 Feb 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Triveni Medichem Private Limited U24100DL2011PTC213927
Director12 Feb 20112011₹15.93 Cr (FY 2025)Active
Avk Impex Private Limited U52100UP2012PTC048477
Director20 Jan 20122012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Triveni Medichem Private Limited
Avk Impex Private Limited
Premium access

Shareholding and investment profile for Hansa Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hansa Agarwal

Hansa Agarwal was first appointed on 12 Feb 2011 as Director at Triveni Medichem Private Limited. The most recent appointment on record is 20 Jan 2012 at Avk Impex Private Limited.

Hansa Agarwal held 2 earlier board appointments: Triveni Medichem Private Limited (Director, 12 Feb 2011 to 30 Jun 2025); Avk Impex Private Limited (Director, 20 Jan 2012 to 30 Mar 2016).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available